Enzolytics Inc (ENZC)

[foxi]

They have to keep mAbs operations under NDA if it risks compromising opportunities for patents. That doesn't mean mAbs operations have stopped. We should still get news about production, clinical trials, etc when the time comes for that.

ITV-1 is already patented so we should still get news about that.

If they ever finish the audit they could attempt to uplist to a more regulated OTC tier (reducing certain investor risks).

If they can afford to push their in-vitro diagnostic AI platform and veterinary mAbs, they could probably get those to market faster than human mAbs.

The market will probably agree to trade at a lower level for awhile, but the story isn't over yet. I'm with the commenters who feel bad recommending this to friends and family, since a lot of those people may not be able to wait this out, and sell for a big loss.




.